| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4447159
Max Phase: Preclinical
Molecular Formula: C26H22N6O3
Molecular Weight: 466.50
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1c(C(O)CN2CCc3nc(-n4ncc5c(C#N)cccc54)ncc3C2)ccc2c1COC2=O
Standard InChI: InChI=1S/C26H22N6O3/c1-15-18(5-6-19-21(15)14-35-25(19)34)24(33)13-31-8-7-22-17(12-31)10-28-26(30-22)32-23-4-2-3-16(9-27)20(23)11-29-32/h2-6,10-11,24,33H,7-8,12-14H2,1H3
Standard InChI Key: VMPKTXAZPLMKEZ-UHFFFAOYSA-N
Associated Targets(Human)
ATP-sensitive inward rectifier potassium channel 1 862 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 466.50 | Molecular Weight (Monoisotopic): 466.1753 | AlogP: 2.76 | #Rotatable Bonds: 4 |
| Polar Surface Area: 117.16 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.60 | CX Basic pKa: 7.18 | CX LogP: 2.86 | CX LogD: 2.66 |
| Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.46 | Np Likeness Score: -1.00 |
References
| 1. Aretz CD, Vadukoot AK, Hopkins CR.. (2019) Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics., 62 (19): [PMID:31034224] [10.1021/acs.jmedchem.8b01891] |
Source
Source(1):